Zealand Pharma — Juni 2024
-
Zealand efter tre rekorder på stribe: Indleder salg af nye aktier for over 6 mia. kr https://proinvestor.com/investornyt/1177424/zealand-efter-tre-rekorder-pa-stribe-indleder-salg-af-nye-aktier-for-over-6-mia-kr
-
Jeg synes, det er et progressivt og stærkt træk. De udnytter i den grad momentum, og jeg er overbevist om, at det bliver en ganske høj kurs, de nye aktier bliver udbudt til. Det kan lyde lidt paradoksalt, når et selskab er ude at hente penge hos investorerne, men jeg synes faktisk Zealand viser muskler her. De ved, de har noget, som mange gerne vil have fingrene i, og det stiller dem stærkt.
-
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion.
-
A directed share offering to certain institutional and professional investors through an accelerated bookbuilding process previously announced has due to strong investor demand been upsized from USD 900 million / DKK 6.257 billion to approximately USD 1 billion / DKK 7 billion
-
-
Zealand Pharma øger annonceret aktiesalg med 700 mio. kr.
Zealand Pharma har øget sit salg af nye aktier fra 900 mio. dollar til ca. 1 mia. dollar, grundet stærk efterspørgsel fra institutionelle investorer.
(medwatch.dk)
-
Godmorgen
-
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
-
The new shares will be issued at a subscription price of DKK 843 per new share. The aggregate gross proceeds from the issue will amount to USD 1 billion / DKK 7 billion and Zealand intends to use the net proceeds to advance Zealand’s proprietary obesity programs in Phase 2b clinical trials and beyond, including investment in associated CMC activities, and pursue clinical development in related indications with the potential to provide additional therapeutic benefits to patients.
-
The net proceeds
26/6 2024 05:55
are also expected to support continued early-stage research and fund general corporate purposes. -
Zealand Pharma henter nye penge: Vildt, bemærkelsesværdigt, usædvanligt! https://proinvestor.com/boards/121078
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1177634/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind